Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-21

FDA Approved: NYSTATIN — Original Application (Leading Pharma, LLC)

View source ↗

Summary

The FDA has approved an original ANDA for NYSTATIN from Leading Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nystatin (Nystatin)

Snippet

ORIG AP for NYSTATIN (NYSTATIN)